
New Key Publication: Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion

Background and aims: The assembly and secretion of very low-density lipoproteins (VLDL) from the liver, a pathway that affects hepatic and plasma lipids, remains incompletely understood. We set out to identify new players in the VLDL biogenesis pathway through identifying genes that are co-expressed with the MTTP gene which encodes for microsomal triglyceride transfer protein (MTP), key to the lipidation of apolipoprotein (apo) B, the core protein of VLDL. Using human and murine transcriptomic datasets, we identified SMLR1, encoding for small leucine-rich protein 1, a protein of unknown function, which is exclusively expressed in liver and small intestine.
Approach and results: To assess the role of SMLR1 in the liver, we used somatic CRISPR/Cas9 gene editing to silence murine Smlr1 in hepatocytes (Smlr1-LKO). When fed a chow diet, male and female mice show hepatic steatosis, reduced plasma apoB and triglycerides, and reduced VLDL secretion without affecting MTP activity. Immunofluorescence studies show that SMLR1 is in the endoplasmic reticulum (ER) and Cis-Golgi complex. The loss of hepatic SMLR1 in female mice protects against diet-induced hyperlipidemia and atherosclerosis but causes non-alcoholic steatohepatitis (NASH). On a high-fat high cholesterol diet insulin and glucose tolerance tests did not reveal differences in male Smlr1-LKO mice versus controls.
Conclusions: In conclusion, we propose a role for SMLR1 in the trafficking of VLDL from the ER to the Cis-Golgi complex. While this study uncovers SMLR1 as a new player in the VLDL assembly, trafficking, and secretion pathway, it also shows that NASH can occur with undisturbed glucose homeostasis and atheroprotection.
Authors:
- Willemien van Zwol
- Antoine Rimbert
- Justina C Wolters
- Marieke Smit
- Vincent W Bloks
- Niels J Kloosterhuis
- Nicolette Huijkman
- Mirjam H Koster
- Umesh Tharehalli
- Simon M de Neck
- Colin Bournez
- Marceline M Fuh
- Jeroen Kuipers
- Sujith Rajan
- Alain de Bruin
- Henry N Ginsberg
- Gerard JP van Westen
- M Mahmood Hussain
- Ludger Scheja
- Joerg Heeren
- Philip Zimmerman
- Bart van de Sluis
- Jan Albert Kuivenhoven
Read More: Hepatology 2022 Sep 2. doi: 10.1002/hep.32709. [Pubmed]
Last modified: | 05 September 2022 10.19 a.m. |
More news
-
24 March 2025
UG 28th in World's Most International Universities 2025 rankings
The University of Groningen has been ranked 28th in the World's Most International Universities 2025 by Times Higher Education. With this, the UG leaves behind institutions such as MIT and Harvard. The 28th place marks an increase of five places: in...
-
05 March 2025
Women in Science
The UG celebrates International Women’s Day with a special photo series: Women in Science.
-
16 December 2024
Jouke de Vries: ‘The University will have to be flexible’
2024 was a festive year for the University of Groningen. In this podcast, Jouke de Vries, the chair of the Executive Board, looks back.